View in EDS HTML Full Text PDF Full Text

ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis.

Saved in:
Bibliographic Details
Title: ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis.
Authors: Shen FF; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Li DF; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Kong LB; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Li JL; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Ma SL; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Jiang HZ; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Yuan HZ; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Jin Y; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China., Chen ZG; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China., Guo XJ; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Dong GP; School of Pharmacy, Xinxiang Medical University, Xinxiang, Henan, China., Lu DR; Department of Gastroenterology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China., Zhong JT; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan, China.
Source: Frontiers in immunology [Front Immunol] 2026 Mar 06; Vol. 17, pp. 1752827. Date of Electronic Publication: 2026 Mar 06 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41869309
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shen+FF%22">Shen FF</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Li+DF%22">Li DF</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Kong+LB%22">Kong LB</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Li+JL%22">Li JL</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Ma+SL%22">Ma SL</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Jiang+HZ%22">Jiang HZ</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Yuan+HZ%22">Yuan HZ</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Jin+Y%22">Jin Y</searchLink>; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Chen+ZG%22">Chen ZG</searchLink>; School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Guo+XJ%22">Guo XJ</searchLink>; The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Dong+GP%22">Dong GP</searchLink>; School of Pharmacy, Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Lu+DR%22">Lu DR</searchLink>; Department of Gastroenterology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.<br /><searchLink fieldCode="AU" term="%22Zhong+JT%22">Zhong JT</searchLink>; Department of Pathology, Xinxiang Medical University, Xinxiang, Henan, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Mar 06; Vol. 17, pp. 1752827. <i>Date of Electronic Publication: </i>2026 Mar 06 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41869309
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1752827
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1752827
    Titles:
      – TitleFull: ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shen FF
      – PersonEntity:
          Name:
            NameFull: Li DF
      – PersonEntity:
          Name:
            NameFull: Kong LB
      – PersonEntity:
          Name:
            NameFull: Li JL
      – PersonEntity:
          Name:
            NameFull: Ma SL
      – PersonEntity:
          Name:
            NameFull: Jiang HZ
      – PersonEntity:
          Name:
            NameFull: Yuan HZ
      – PersonEntity:
          Name:
            NameFull: Jin Y
      – PersonEntity:
          Name:
            NameFull: Chen ZG
      – PersonEntity:
          Name:
            NameFull: Guo XJ
      – PersonEntity:
          Name:
            NameFull: Dong GP
      – PersonEntity:
          Name:
            NameFull: Lu DR
      – PersonEntity:
          Name:
            NameFull: Zhong JT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 03
              Text: 2026 Mar 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1